ADVERTISEMENT

OT: Stock and Investment Talk

I wonder what would happen if at the end of the year you do the reverse? Take the 25 worst performers in 2023 and see what happens in 2024. Would they tank more or regress to the mean (i.e., rally big time!).

Great table, thanks for posting.
I think its safe to say the top 25 sucked last year.
 
Paul Sankey was on fast money this week talking oil.
.

All the OPEC cuts keeping prices high have encouraged US growth. US companies will continue to grow above $60 per barrel.

Says look for a Saudi flood of the market to flush prices and stop US growth.
 
Last edited:
  • Like
Reactions: T2Kplus20
Always enjoy listening to him speak. Has anyone actually ever paid for his picks at FSInsight?

Yes, I have been getting his research since last summer. Signed up for a 30-day free trial and then was offered a highly discounted rate since I'm an individual investor. Still expensive, but definitely worth it. You get almost daily videos from Tom Lee and Mark Newton (Head of TA for Fundstrat). Multiple 1-hour webinars each month. Tons of great stuff.

Most importantly, Tom and the team's stock list (about 35 stocks) has crushed the S&P 500 since it started in 2019. Beat the S&P 500 easily every year.

2019 = 33.2% vs. 24.4%
2020 = 46.4% vs. 16.3%
2021 = 30.8% vs. 26.9%
2022 = -15.5% vs. -19.4
2023 (YTD) = 24.4% vs. 19.7%

Send me a DM/conversation if you want to learn more. I can make referrals.
 
Paul Sankey was on fast money this week talking oil.
.

All the OPEC cuts keeping prices high have encouraged US growth. US companies will continue to grow above $60 per barrel.

Says look for a Saudi flood of the market to flush prices and stop US growth.
I closed my CVX calls for now (made almost 10%). Need to research the Saudi flush possibility. It they do so, it would create an amazing buying opportunity due to the artificial/temporary drop in oil prices. Still think CVX is a great play.
 
Almost everything sucked last year.
I'll check for the top performing S&P and Nasdaq stocks every week and make
my buy/sell decisions.
Not Energy and healthcare.

But yeah overall most stocks were down and that did make my assumption pretty likely
 
  • Like
Reactions: T2Kplus20
BTC up over $40K.
It is looking more and more likely that all/most BTC spot ETFs will be approved prior to the next "final deadline" on January 10th. The crypto market make keep pumping through the holidays. Are you planning for any stock plays? Perhaps MARA calls.

I have a nice amount of BTC and ETH via Fidelity. Not too much to worry about if something goes wrong, but enough to feel good about a pump.

@ScarletNut and @rurahrah000 (love to hear from both of you as well).
 
It is looking more and more likely that all/most BTC spot ETFs will be approved prior to the next "final deadline" on January 10th. The crypto market make keep pumping through the holidays. Are you planning for any stock plays? Perhaps MARA calls.

I have a nice amount of BTC and ETH via Fidelity. Not too much to worry about if something goes wrong, but enough to feel good about a pump.

@ScarletNut and @rurahrah000 (love to hear from both of you as well).
I had bought GBTC. Not much though.

And I own some ATOM coins, which I bought because of a 20% yield, but NJ passed a law and NJ residents can't collect the yield. But the price has appreciated, will sell it eventually.
 
  • Like
Reactions: T2Kplus20
I had bought GBTC. Not much though.

And I own some ATOM coins, which I bought because of a 20% yield, but NJ passed a law and NJ residents can't collect the yield. But the price has appreciated, will sell it eventually.
A little skin in the game is good. ATOM is up about 25% in the past month.

Just to remind everyone:

CRSP = PDUFA is this Friday, highly likely the FDA approves their sickle cell anemia gene therapy (almost a certainty)

BLUE = PDUFA is December 20 for their sickle cell anemia gene therapy, also highly likely for approval, and they should bounce hard even with the CRSP approval.

And remember, the FDA can issue a decision earlier than PDUFA. That's the deadline for review unless the FDA requests more data/information (which doesn't seem likely in either case).
 
Last edited:
  • Like
Reactions: RU-05
in at 65 area with sizable purchase. will exit most soon as it's a good return
Pre-revenue biotech (which is most of the XBI) is probably the most interest rate sensitive sub-sector due to the need for financing. Great play if you think rates will continue to drift lower.
 
  • Like
Reactions: RUTGERS95
It is looking more and more likely that all/most BTC spot ETFs will be approved prior to the next "final deadline" on January 10th. The crypto market make keep pumping through the holidays. Are you planning for any stock plays? Perhaps MARA calls.

I have a nice amount of BTC and ETH via Fidelity. Not too much to worry about if something goes wrong, but enough to feel good about a pump.

@ScarletNut and @rurahrah000 (love to hear from both of you as well).
I have a good amount of BTC and ETH. I have a ton of RIOT and MARA shares along with lots of calls expiring in the next month. I will continue to roll them until I feel the run is over.


A little skin in the game is good. ATOM is up about 25% in the past month.

Just to remind everyone:

CRSP = PDUFA is this Friday, highly likely the FDA approves their sickle cell anemia gene therapy (almost a certainty)

BLUE = PDUFA is December 20 for their sickle cell anemia gene therapy, also highly likely for approval, and they should bounce hard even with the CRSP approval.

And remember, the FDA can issue a decision earlier than PDUFA. That's the deadline for review unless the FDA requests more data/information (which doesn't seem likely in either case).
I do have BLUE calls and to a smaller extent CRSP calls. I will buy more $4.5 BLUE calls tomorrow.
 
  • Like
Reactions: T2Kplus20
I have a good amount of BTC and ETH. I have a ton of RIOT and MARA shares along with lots of calls expiring in the next month. I will continue to roll them until I feel the run is over.



I do have BLUE calls and to a smaller extent CRSP calls. I will buy more $4.5 BLUE calls tomorrow.
I need to pick up MARA calls today (and maybe RIOT). By the way, do you wait for expiration day to roll calls or do you do it earlier? Not sure if there is a good rule of thumb for rolling.

EDIT: Finally started a PLTR position this morning, high $18s. Will add as opportunities allow.
 
Last edited:
I need to pick up MARA calls today (and maybe RIOT). By the way, do you wait for expiration day to roll calls or do you do it earlier? Not sure if there is a good rule of thumb for rolling.

EDIT: Finally started a PLTR position this morning, high $18s. Will add as opportunities allow.
Any idea why PLTR sold off? Merely an expensive stock cooling off after a big run?
 
Sold WFC (slight gain) and REI (decent loss).

Bought NJR looks to be bouncing and a similar div as WFC

Still have a couple bucks to spend.
 
Any idea why PLTR sold off? Merely an expensive stock cooling off after a big run?
Doesn't seem to be any news on PLTR, probably just too far too fast. Seems to be a nice entry point to start a position. Prospects are positive for PLTR to get into the S&P 500 soon. I think they only need one more quarter of profit to be eligible.
 
Sold WFC (slight gain) and REI (decent loss).

Bought NJR looks to be bouncing and a similar div as WFC

Still have a couple bucks to spend.
Biotech/CSPR/BLUE continue to rally, so far today.
 
Any signs of China bottoming? Looks like all ETFs/indexes are back to 52-week lows.
 
Added to TOST.

Should buy a little BLUE.
I'm already up about 60% on the CRSP calls. Options are fun. LOL! As for TOST, they bring in a lot of revenue, but do they have a path to profitability?
 
Call me crazy, but yesterday during extended I started a very small position in YINN (3x of FXI). These China ETFs are back down to 10-year lows (which they also hit in 2022 and then ripped hard). Gotta be close to a bottom, right?
😁
 
  • Like
Reactions: redking and RU-05
Call me crazy, but yesterday during extended I started a very small position in YINN (3x of FXI). These China ETFs are back down to 10-year lows (which they also hit in 2022 and then ripped hard). Gotta be close to a bottom, right?
😁
Falling knife.

But ENPH was a falling knife, until it wasn't. Up 50% in like a month.
 
  • Like
Reactions: T2Kplus20
ADVERTISEMENT
ADVERTISEMENT